Triglycerides
Plozasiran lowers triglycerides, reduces pancreatitis risk in chylomicronemia
In patients with persistent chylomicronemia, plozasiran, a small interfering RNA therapy, was associated with lower triglyceride levels and reduced risk for pancreatitis, researchers reported at the European Society of Cardiology Congress.
Insulin resistance measure may be ‘simple and cost-effective’ gout prediction tool
U.S. adults with higher triglyceride glycemic index scores demonstrate a greater likelihood of developing gout, according to data published in the Journal of Health, Population and Nutrition.
Special Clinical Populations
Omega-3 Fatty Acids
Fibrates
Managing Hypertriglyceridemia
Body fat, metabolic changes before pancreatic cancer diagnosis may aid in early detection
In the 36 months prior to diagnosis of pancreatic ductal adenocarcinoma, researchers observed “predominant changes” in patients’ body composition and biochemical markers, which may serve as potential biomarkers for early cancer detection.
Prenatal exposure to EDCs may increase metabolic syndrome risk for children
Children exposed in utero to higher levels of some types of endocrine-disrupting chemicals have a higher risk for developing metabolic syndrome, according to findings published in JAMA Network Open.
Olezarsen reduces triglycerides, pancreatitis events in familial chylomicronemia syndrome
Monthly olezarsen 80 mg significantly lowered triglyceride levels and also reduced incidence of acute pancreatitis vs. placebo in patients with familial chylomicronemia syndrome, according to a study in The New England Journal of Medicine.
VIDEO: Olezarsen reduces high triglyceride, ApoC-III levels
ATLANTA — In this Healio video exclusive, Erica S. Spatz, MD, MHS, discusses research into lipid disorders from the American College of Cardiology Scientific Session, examining studies aimed at reducing high triglycerides.